Key Highlights

  • Shares are trading at $6.31, up 6.23% in Thursday's session.
  • Citi upgraded the stock to Buy from Neutral, though the bank trimmed its price target to $7 from $9.
  • The upgrade comes despite the stock trading more than 75% below its $23.50 September 2025 IPO price, near its 52-week low around $5.75-$6.
  • Analyst sentiment remains mixed: Bank of America recently downgraded the stock to Underperform citing weak Volume expectations and regulatory pressure, while Guggenheim maintained a Neutral rating with a lowered target.

Citi Upgrade Lifts Shares Despite a Mixed Analyst Backdrop

StubHub Holdings (NYSE:STUB) shares rose sharply in Thursday's session after Citi upgraded the stock to Buy from Neutral, even as the bank simultaneously trimmed its price target to $7 from $9. StubHub operates the world's leading online secondary ticketing marketplace, connecting fans, sellers, and partners for live events such as sports, concerts, and theater performances under the StubHub Brand in North America and viagogo internationally, serving customers in over 90 countries.

The upgrade stands out against a backdrop of otherwise mixed analyst sentiment following the ticketing marketplace's post-IPO slide of more than 75% from its $23.50 September 2025 debut price to levels near its 52-week low around $5.75-$6.

Bank of America and Guggenheim Strike a More Cautious Tone

Not all analysts share Citi's optimism: Bank of America recently downgraded the stock to Underperform, citing weak volume expectations and regulatory pressure facing the ticket-resale industry, while Guggenheim maintained a Neutral rating with a lowered target, reflecting persistent concerns about profitability and Debt levels even after today's bounce.

Investors Weigh Strong Growth Against Industry Headwinds

Investors are weighing StubHub's strong second-quarter growth and raised full-year gross merchandise value outlook against persistent concerns over profitability, debt levels, and regulatory pressure facing the ticket-resale industry, with the average analyst price target of roughly $11 implying substantial theoretical upside despite the stock's steep decline since listing.